BETTER OUTCOMES BETTER EXPERIENCE
NOVABLOC™ is a breakthrough, non-opioid therapy that delivers targeted, long-lasting postoperative pain relief through a novel electrical stimulation paradigm. NOVABLOC™ offers a powerful alternative to traditional medications and may reduce the risks of opioid dependency¹.
NOVABLOC™ is currently undergoing a randomized controlled trial in the US. Pilot studies have demonstrated continuous pain reduction lasting up to 20 days of continuous postoperative pain relief following knee replacement surgery—with limited use of opioids and without impairing motor function¹.
Synaptrix is redefining postsurgical pain management with NOVABLOC™, delivering improved outcomes and reducing complications. Powered by cutting-edge science, NOVABLOC™ empowers clinicians to enhance patient care and accelerate recovery.
Synaptrix aims to expand its NOVABLOC™ technology platform across a range of clinical applications, shaping the future of opioid-free recovery and contributing to a broader transformation in perioperative care.
NOVABLOC™
Synaptrix is a clinical-stage medical technology company based in Atlanta, Georgia, dedicated to revolutionizing the post-surgical experience by eliminating the need for opioids. Backed by a leadership team with decades of experience in medtech innovation and commercialization, Synaptrix is advancing a new standard in pain management through proprietary neuromodulation science.
1. Grant SA, Auyong D, Alexeeva N, Schepis E. Radiofrequency Stimulation for Regional Analgesia After Total Knee Arthroplasty. Abstract presented at: American Society of Regional Anesthesia and Pain Medicine (ASRA) 49th Annual Meeting; 2025 May 3; Orlando, FL.